Official Publications TME Pharma N.V.

Equities

Real-time Euronext Paris Other stock markets 04:48:52 2024-04-26 am EDT			5-day change	1st Jan Change
0.24 ^EUR	-3.42%		-4.57%	+4.35%

Apr. 23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI
Apr. 03	TME Pharma: Fast Track designation in glioblastoma	CF

Admission of new securities	Dec. 13	CO
Admission of new securities	Dec. 13	CO
Half-year report	23-10-26	CO
1st-half-year results	23-10-26	CO
1st-half-year results	23-10-26	CO
Minutes of the general assembly	23-06-29	CO
Minutes of the general assembly	23-06-29	CO
Mixed general shareholder meeting	23-05-29	CO
Mixed general shareholder meeting	23-05-29	CO
Annual Report	23-04-23	CO
Annual results	23-04-17	CO
Annual results	23-04-17	CO
Minutes of the general assembly	23-01-29	CO
Minutes of the general assembly	23-01-29	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-02	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-01-01	CO
Changes in management and corporate officers	22-11-27	CO
Changes in management and corporate officers	22-11-27	CO
Half-year report	22-10-25	CO
1st-half-year results	22-10-25	CO
1st-half-year results	22-10-25	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	22-09-12	CO
Change of company name	22-07-14	CO
Change of company name	22-07-14	CO